LLYbenzinga

Eli Lilly Doubles Capital Spending On US Drug Manufacturing With $50 Billion Target (CORRECTED)

Summary

Eli Lilly is investing over $50 billion in U.S. manufacturing, adding four new sites to boost domestic medicine production and create thousands of jobs.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on February 28, 2025 by benzinga